Narae Nanotech Corporation (KOSDAQ: 137080)
South Korea
· Delayed Price · Currency is KRW
2,765.00
-105.00 (-3.66%)
Nov 15, 2024, 9:00 AM KST
Narae Nanotech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Operating Revenue | 31,842 | 52,926 | 88,040 | 135,153 | 82,805 | 43,008 |
Other Revenue | - | - | - | -0 | - | - |
Revenue | 31,842 | 52,926 | 88,040 | 135,153 | 82,805 | 43,008 |
Revenue Growth (YoY) | -64.87% | -39.89% | -34.86% | 63.22% | 92.53% | - |
Cost of Revenue | 41,433 | 56,326 | 75,808 | 100,546 | 68,008 | 45,668 |
Gross Profit | -9,591 | -3,401 | 12,232 | 34,607 | 14,797 | -2,660 |
Selling, General & Admin | 9,333 | 8,889 | 9,370 | 10,716 | 8,466 | 6,881 |
Other Operating Expenses | 92.96 | 79.79 | 91.31 | 129.85 | 87.12 | 217 |
Operating Expenses | 12,184 | 11,590 | 10,276 | 11,483 | 9,147 | 7,632 |
Operating Income | -21,775 | -14,991 | 1,956 | 23,123 | 5,650 | -10,292 |
Interest Expense | -3,078 | -2,750 | -1,351 | -1,309 | -1,560 | -1,922 |
Interest & Investment Income | 274.24 | 277.74 | 231.52 | 21.45 | 30.02 | 12.81 |
Currency Exchange Gain (Loss) | 1,361 | 350.73 | 691.56 | 483.48 | -635.76 | 115.36 |
Other Non Operating Income (Expenses) | -329.27 | 63.21 | 212 | 96.9 | 97.4 | 130.94 |
EBT Excluding Unusual Items | -23,548 | -17,050 | 1,740 | 22,416 | 3,581 | -11,955 |
Gain (Loss) on Sale of Investments | 18.49 | 368.28 | 7.48 | 8.23 | 1.47 | 8.33 |
Gain (Loss) on Sale of Assets | 27.89 | -8.33 | 161.81 | 30.05 | -670.26 | -26.17 |
Asset Writedown | - | - | 751.63 | - | - | -3.6 |
Pretax Income | -23,502 | -16,690 | 2,661 | 22,454 | 2,913 | -11,977 |
Income Tax Expense | -4,314 | -3,406 | 138.9 | 4,982 | 679.91 | -1,081 |
Net Income | -19,188 | -13,283 | 2,522 | 17,472 | 2,233 | -10,895 |
Net Income to Common | -19,188 | -13,283 | 2,522 | 17,472 | 2,233 | -10,895 |
Net Income Growth | - | - | -85.57% | 682.56% | - | - |
Shares Outstanding (Basic) | 11 | 11 | 11 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 8 | 8 | 8 |
Shares Change (YoY) | 0.29% | 1.82% | 29.43% | - | - | - |
EPS (Basic) | -1733.57 | -1201.10 | 232.18 | 2081.91 | 266.04 | -1298.26 |
EPS (Diluted) | -1733.57 | -1201.10 | 232.00 | 2081.91 | 266.00 | -1298.26 |
EPS Growth | - | - | -88.86% | 682.67% | - | - |
Free Cash Flow | -17,290 | -31,449 | -35,831 | 14,661 | 9,907 | -14,603 |
Free Cash Flow Per Share | -1562.06 | -2843.63 | -3298.70 | 1746.93 | 1180.53 | -1740.07 |
Dividend Per Share | - | - | 100.000 | 200.000 | - | - |
Dividend Growth | - | - | -50.00% | - | - | - |
Gross Margin | -30.12% | -6.43% | 13.89% | 25.61% | 17.87% | -6.19% |
Operating Margin | -68.38% | -28.32% | 2.22% | 17.11% | 6.82% | -23.93% |
Profit Margin | -60.26% | -25.10% | 2.86% | 12.93% | 2.70% | -25.33% |
Free Cash Flow Margin | -54.30% | -59.42% | -40.70% | 10.85% | 11.96% | -33.95% |
EBITDA | -15,695 | -10,063 | 4,581 | 25,495 | 8,085 | -7,806 |
EBITDA Margin | -49.29% | -19.01% | 5.20% | 18.86% | 9.76% | -18.15% |
D&A For EBITDA | 6,080 | 4,928 | 2,625 | 2,372 | 2,435 | 2,487 |
EBIT | -21,775 | -14,991 | 1,956 | 23,123 | 5,650 | -10,292 |
EBIT Margin | -68.38% | -28.32% | 2.22% | 17.11% | 6.82% | -23.93% |
Effective Tax Rate | - | - | 5.22% | 22.19% | 23.34% | - |
Advertising Expenses | - | 7.13 | 14.09 | 1.01 | 11.33 | 3.08 |
Source: S&P Capital IQ. Standard template. Financial Sources.